Literature DB >> 26607969

Should we question early feminizing genitoplasty for patients with congenital adrenal hyperplasia and XX karyotype?

A Binet1, H Lardy2, D Geslin3, C Francois-Fiquet4, M L Poli-Merol4.   

Abstract

BACKGROUND: There is a wide difference of opinion between the medical-surgical community and advocacy group regarding Disorders of Sexual Development (DSD) secondary to congenital adrenal hyperplasia (CAH) being ranked in the intersex category. This rupture is even more evident when the issue of genitoplasty is brought up. For physicians it is obvious and unequivocal that a person with CAH and an XX karyotype has a female gender identity, whereas associations tend to rank persons with CAH in the intersex category and advocate holding-off on surgical management. MATERIAL/
METHODS: A retrospective case study vs. control group, spanning over 40years, included 21 patients who were treated in 3 different centers. Each patient and their parents were contacted independently and interviewed regarding interpersonal relationships, psychological impact of genitoplasty, gender identity and opinion on optimal care management for this disorder. Three couples controls (parent-child) per CAH patients were used and matched according to age, sex assigned at birth and ethnic origin.
RESULTS: Sex assigned at birth seemed to concord with the gender identity perceived by the patients in 85.7% of cases. In fact, 89.7% of patients and 100% of parents felt that feminizing genitoplasty should be performed within the first year of life. There is however a significant difference compared to controls who felt that surgical management should occur later on in life. No difference was highlighted during childhood regarding parents-child relationships or social integration. However, during adolescence, the parents-child relationship tended to be significantly more painful for the CAH group. Integrating their parenting role was significantly harder for patients in the CAH-DSD group. In the population of CAH-DSD patients who had genitoplasty the level of sexual fulfillment was not lower to the one reported by the control group.
CONCLUSION: Female sex assignment seems legitimate according to this study and the development of gender identity in these patients matches the sex assigned at birth. Resolving early on the adequacy of the genital anatomy with the sex assigned is promoted by patients as well as their parents. Proper psychomotor development and sexual satisfaction underline the absence of complications related to the surgical technique and the relevance of early surgical management.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital adrenal hyperplasia; Gender identity; Interpersonal relationships; Plastic surgery; Relationships between family and healthcare professionals

Mesh:

Year:  2015        PMID: 26607969     DOI: 10.1016/j.jpedsurg.2015.10.004

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  15 in total

Review 1.  Disorders of sex development.

Authors:  Selma Feldman Witchel
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2017-11-22       Impact factor: 5.237

2.  Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).

Authors:  Tomohiro Ishii; Kenichi Kashimada; Naoko Amano; Kei Takasawa; Akari Nakamura-Utsunomiya; Shuichi Yatsuga; Tokuo Mukai; Shinobu Ida; Mitsuhisa Isobe; Masaru Fukushi; Hiroyuki Satoh; Kaoru Yoshino; Michio Otsuki; Takuyuki Katabami; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2022-04-10

3.  Care of the adolescent patient with congenital adrenal hyperplasia: Special considerations, shared decision making, and transition.

Authors:  Reeti Chawla; Meilan Rutter; Janet Green; Erica M Weidler
Journal:  Semin Pediatr Surg       Date:  2019-09-20       Impact factor: 2.754

4.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 5.  Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Authors:  Hedi L Claahsen-van der Grinten; Phyllis W Speiser; S Faisal Ahmed; Wiebke Arlt; Richard J Auchus; Henrik Falhammar; Christa E Flück; Leonardo Guasti; Angela Huebner; Barbara B M Kortmann; Nils Krone; Deborah P Merke; Walter L Miller; Anna Nordenström; Nicole Reisch; David E Sandberg; Nike M M L Stikkelbroeck; Philippe Touraine; Agustini Utari; Stefan A Wudy; Perrin C White
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

6.  Should CAH in Females Be Classified as DSD?

Authors:  Ricardo González; Barbara M Ludwikowski
Journal:  Front Pediatr       Date:  2016-05-13       Impact factor: 3.418

7.  Navigating Surgical Decision Making in Disorders of Sex Development (DSD).

Authors:  Melissa Gardner; David E Sandberg
Journal:  Front Pediatr       Date:  2018-11-19       Impact factor: 3.418

Review 8.  Treatment of the Enlarged Clitoris.

Authors:  Martin Kaefer; Richard C Rink
Journal:  Front Pediatr       Date:  2017-08-28       Impact factor: 3.418

9.  Early Feminizing Genitoplasty in Girls with Congenital Adrenal Hyperplasia (CAH)-Analysis of Unified Surgical Management.

Authors:  Grzegorz Kudela; Aneta Gawlik; Tomasz Koszutski
Journal:  Int J Environ Res Public Health       Date:  2020-05-29       Impact factor: 3.390

10.  Is It Beneficial to Patients to Include Congenital Adrenal Hyperplasia (CAH) Among the Disorders of Sex Development (DSD)?

Authors:  Ricardo González; Barbara M Ludwikowski
Journal:  Front Pediatr       Date:  2018-11-12       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.